The Indian generic industry is responsible for about 40% of all the generic drugs in America. It produces about $50 billion worth of drugs a year through 10,000 factories. There have been some very, very scathing books that have been issued on the subject. The Truth Bill by a former drug executive, a lawyer in India, found many, many areas wanting. And so, if we're going to have a truly global drug industry, we's going to have to have another system which can provide confidence and safety.
Iran’s protests may have gone quiet for the moment, but that does not mean they’ve been defeated. Beneath a calmer surface, Iranians are seething and biding their time. India’s pharma sector is huge, but has long been dogged by concerns about quality control. And we reveal last year’s most newsworthy subject.
For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer